Steve Schonfeld’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.52M Buy
+221,420
New +$5.76M 0.02% 658
2026
Q2
– Sell
-120,689
Closed -$2.52M – 3005
2026
Q1
$2.52M Buy
+120,689
New +$1.68M 0.02% 728
2024
Q1
– Sell
-56,400
Closed -$558K – 2411
2023
Q4
$558K Buy
56,400
+15,106
+37% +$131K ﹤0.01% 1246
2023
Q3
$465K Buy
+41,294
New +$252K ﹤0.01% 1224
2022
Q4
– Sell
-16,000
Closed -$58K – 3008
2022
Q3
$58K Buy
+16,000
New +$68.3K ﹤0.01% 2623

Other funds holding TNGX

Steve Schonfeld's TNGX Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 221,420 shares worth $5.52M. The stake represents 0.02% of the portfolio and ranks #658 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in TNGX as recently as Q1 2026.

Steve Schonfeld first reported a position in TNGX in Q3 2022 and has held it in 5 quarters since. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Steve Schonfeld held 221,420 shares of Tango Therapeutics worth $5.52M as of Q3 2026.
  • Tango Therapeutics was a new Steve Schonfeld position in Q3 2026.
  • Tango Therapeutics made up 0.02% of Steve Schonfeld's portfolio in Q3 2026, its #658 holding.
  • Steve Schonfeld first reported a position in Tango Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.